Physician profile
William Delgado
NPI 1184643249
$1,342.69
in general payments reported to CMS, 2019-2025
17 companies · $76.47 in 2025
The $76.47 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2021: $67.92 · 2022: $297 · 2023: $190 · 2024: $393 · 2025: $76.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598 · Education: $60.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.08 |
| Education | $60.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $243.00 | 2019-2024 | Bimzelx |
| Abbvie INC. | $215.18 | 2019-2025 | Rinvoq |
| Merz North America, INC. | $153.55 | 2022 | |
| Janssen Biotech, INC. | $149.11 | 2022-2024 | Tremfya |
| Lilly USA, LLC | $128.31 | 2019-2024 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $105.53 | 2019-2024 | Ilumya |
| Novartis Pharmaceuticals Corporation | $70.69 | 2019-2024 | |
| Genzyme Corporation | $44.31 | 2019 | |
| Arcutis Biotherapeutics, INC. | $39.58 | 2023 | |
| Pfizer INC. | $33.61 | 2024 | |
| Galderma Laboratories, L.P. | $31.54 | 2024-2025 | |
| Organon LLC | $30.01 | 2024-2025 | Vtama |
| Organogenesis INC. | $27.82 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $19.70 | 2019 | |
| Biofrontera INC. | $19.08 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.39 | 2019 | |
| Leo Pharma INC. | $15.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Delgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.